Position in BSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,364,436
-$858,649 QoQ
Shares Held
21,744
-6.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Smartleaf Asset Management LLC holds $11,982,911 across 49 Medical Devices names. BSX ranks #4 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
29,785 | $3,058,025 | |
| 2 | SYK |
Stryker Corp
|
7,995 | $2,627,077 | |
| 3 | MDT |
Medtronic plc
|
23,270 | $2,016,345 | |
| 4 | BSX |
Boston Scientific Corp
This page
|
21,744 | $1,364,436 | |
| 5 | EW |
Edwards Lifesciences Corp
|
6,165 | $493,693 | |
| 6 | PHG |
Koninklijke Philips NV
|
14,841 | $406,643 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,290 | $234,182 | |
| 8 | STE |
STERIS plc
|
879 | $194,373 |
All Filings in BSX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,364,436 | 21,744 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,223,085 | 23,315 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,302,017 | 23,579 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,882,897 | 17,530 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,007,007 | 19,895 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,673,231 | 18,733 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,258,927 | 15,023 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $913,415 | 11,861 | Shares | Sole | 2024-10-08 | |
| 2024-03-31 | $663,188 | 9,683 | Shares | Sole | 2024-10-07 | |
| 2023-12-31 | $406,693 | 7,035 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||